Guidance for the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health: (Revision 1)

EFSA Journal

Volumn 16, Issue 1, 2018, Pages

  Turck, Dominique ^a   Bresson, Jean Louis ^a   Burlingame, Barbara ^a   Dean, Tara ^a   Fairweather Tait, Susan ^a   Heinonen, Marina ^a   Hirsch Ernst, Karen Ildico ^a   Mangelsdorf, Inge ^a   McArdle, Harry J ^a   Naska, Androniki ^a   Neuhäuser Berthold, Monika ^a   Nowicka, Grażyna ^a   Pentieva, Kristina ^a   Sanz, Yolanda ^a   Sjödin, Anders ^a   Stern, Martin ^a   Tomé, Daniel ^a   Van Loveren, Henk ^a   Vinceti, Marco ^a   Willatts, Peter ^a   Martin, Ambroise ^a   Strain, John Joseph ^a   Heng, Leng ^a   Valtueña Martínez, Silvia ^a   Siani, Alfonso ^a   more..

^a NONE

Author keywords

antioxidants; cardiovascular health; guidance; health claims; oxidative damage; scientific requirements

Indexed keywords

EID: 85061985695     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2018.5136     Document Type: Article

References (44)

1. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WM, Vlachopoulos C, Wood DA and Zamorano JL, 2016. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. European Heart Journal, 37, 2999–3058. Available online: https://doi.org/10.1093/eurheartj/ehw272
2. Cattaneo M, Cerletti C, Harrison P, Hayward CP, Kenny D, Nugent D, Nurden P, Rao AK, Schmaier AH, Watson SP, Lussana F, Pugliano MT and Michelson AD, 2013. Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH. Journal of Thrombosis and Haemostasis, 11, 1183–1189. Available online: http://onlinelibrary.wiley.com/doi/10.1111/jth.12231/pdf
3. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J and Vogel R, 2002. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. Journal of the American College of Cardiology, 39, 257–265. Available online: https://www.ncbi.nlm.nih.gov/pubmed/11788217; and more recently discussed in: http://www.ncbi.nlm.nih.gov/pubmed/20952670
4. EFSA (European Food Safety Authority), 2008a. Scientific Opinion of the Panel on Dietetic Products Nutrition and Allergies on a request from Unilever PLC/NV on Plant Sterols and lower/reduced blood cholesterol, reduced the risk of (coronary) heart disease. EFSA Journal 2008;6(8):781, 12 pp. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2008.781/epdf
5. EFSA (European Food Safety Authority), 2008b. Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies on a request from McNeil Nutritionals Ltd. related to the scientific substantiation of a health claim on plant stanol esters and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease. EFSA Journal 2008;6(10):825, 13 pp. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2008.825/epdf
6. EFSA (European Food Safety Authority), 2008c. Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies on a request from Valio Ltd. on the scientific substantiation of a health claim related to Lactobacillus helveticus fermented Evolus® low-fat milk products and reduction of arterial stiffness. EFSA Journal 2008;6(10):824, 12 pp. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2008.824/epdf
7. EFSA (European Food Safety Authority), 2009a. Water-soluble tomato concentrate (WSTC I and II) and platelet aggregation. EFSA Journal 2009;7(5):1101, 15 pp. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2009.1101/epdf
8. EFSA (European Food Safety Authority), 2009b. Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies on a request from Danone France related to the scientific substantiation of a health claim on phytosterols and lowering/reducing blood cholesterol and reduced risk of (coronary) heart disease. EFSA Journal 2009;7(7):1177, 12 pp. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2009.1177/epdf
9. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2009a. Scientific Opinion on the substantiation of health claims related to isoleucine-proline-proline (IPP) and valine-proline-proline (VPP) and maintenance of normal blood pressure (ID 615, 661, 1831, 1832, 2891), and maintenance of the elastic properties of the arteries (ID 1832) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission. EFSA Journal 2009;7(9):1259, 18 pp. https://doi.org/10.2903/j.efsa.2009.1259. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2009.1259/epdf
10. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2009b. Scientific Opinion on the substantiation of health claims related to folate and blood formation (ID 79), homocysteine metabolism (ID 80), energy yielding metabolism (ID 90), function of the immune system (ID 91), function of blood vessels (ID 94, 175, 192), cell division (ID 193), and maternal tissue growth during pregnancy (ID 2882) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission. EFSA Journal 2009; 7(9):1213, 22 pp. https://doi.org/10.2903/j.efsa.2009.1213. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2009.1213/epdf
11. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2010a. Scientific Opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325), maintenance of normal blood glucose concentrations (ID 566), maintenance of normal blood pressure (ID 506, 516, 703, 1317, 1324), maintenance of normal blood HDL-cholesterol concentrations (ID 506), maintenance of normal (fasting) blood concentrations of triglycerides (ID 506, 527, 538, 1317, 1324, 1325), maintenance of normal blood LDL-cholesterol concentrations (ID 527, 538, 1317, 1325, 4689), protection of the skin from photo-oxidative (UV-induced) damage (ID 530), improved absorption of EPA and DHA (ID 522, 523), contribution to the normal function of the immune system by decreasing the levels of eicosanoids, arachidonic acid-derived mediators and pro-inflammatory cytokines (ID 520, 2914), and ”immunomodulating agent” (4690) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010;8(10):1796, 32 pp. https://doi.org/10.2903/j.efsa.2010.1796. Available at http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2010.1796/epdf
12. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2010b. Scientific Opinion on the substantiation of health claims related to vitamin B12 and contribution to normal neurological and psychological functions (ID 95, 97, 98, 100, 102, 109), contribution to normal homocysteine metabolism (ID 96, 103, 106), maintenance of normal bone (ID 104), maintenance of normal teeth (ID 104), maintenance of normal hair (ID 104), maintenance of normal skin (ID 104), maintenance of normal nails (ID 104), reduction of tiredness and fatigue (ID 108), and cell division (ID 212) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010;8(10):1756, 23 pp. https://doi.org/10.2903/j.efsa.2010.1756. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2010.1756/epdf
13. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2010c. Scientific Opinion on the substantiation of health claims related to vitamin B6 and contribution to normal homocysteine metabolism (ID 73, 76, 199), maintenance of normal bone (ID 74), maintenance of normal teeth (ID 74), maintenance of normal hair (ID 74), maintenance of normal skin (ID 74), maintenance of normal nails (ID 74), contribution to normal energy-yielding metabolism (ID 75, 214), contribution to normal psychological functions (ID 77), reduction of tiredness and fatigue (ID 78), and contribution to normal cysteine synthesis (ID 4283) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010;8(10):1759. [24 pp.]. https://doi.org/10.2903/j.efsa.2010.1759. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2010.1759/epdf
14. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2010d. Scientific Opinion on the substantiation of a health claim related to oat beta-glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2010;8(12):1885, 15 pp. https://doi.org/10.2903/j.efsa.2010.1885. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2010.1885/epdf
15. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2011a. Guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health. EFSA Journal 2011;9(12):2474, 13 pp. https://doi.org/10.2903/j.efsa.2011.2474. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2011.2474/pdf
16. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2011b. Scientific Opinion on the substantiation of health claims related to foods with reduced amounts of saturated fatty acids (SFAs) and maintenance of normal blood LDL-cholesterol concentrations (ID 620, 671, 4332) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2011;9(4):2062, 14 pp. https://doi.org/10.2903/j.efsa.2011.2062. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2011.2062/epdf
17. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2011c. Scientific Opinion on the substantiation of health claims related to the replacement of mixtures of saturated fatty acids (SFAs) as present in foods or diets with mixtures of monounsaturated fatty acids (MUFAs) and/or mixtures of polyunsaturated fatty acids (PUFAs), and maintenance of normal blood LDL-cholesterol concentrations (ID 621, 1190, 1203, 2906, 2910, 3065) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2011;9(4):2069, 18 pp. https://doi.org/10.2903/j.efsa.2011.2069. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2011.2069/pdf
18. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2011d. Scientific Opinion on the substantiation of health claims related to betaine and contribution to normal homocysteine metabolism (ID 4325) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2011;9(4):2052, 14 pp. https://doi.org/10.2903/j.efsa.2011.2052. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2011.2052/epdf
19. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2011e. Scientific Opinion on the substantiation of health claims related to choline and contribution to normal lipid metabolism (ID 3186), maintenance of normal liver function (ID 1501), contribution to normal homocysteine metabolism (ID 3090), maintenance of normal neurological function (ID 1502), contribution to normal cognitive function (ID 1502), and brain and neurological development (ID 1503) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2011;9(4):2056, 23 pp. https://doi.org/10.2903/j.efsa.2011.2056. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2011.2056/epdf
20. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2011f. Scientific Opinion on the substantiation of a health claim related to barley beta-glucan and lowering of blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2011;9(12):2470, 14 pp. https://doi.org/10.2903/j.efsa.2011.2470. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2011.2470/epdf
21. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2011g. Scientific Opinion on the substantiation of a health claim related to “low fat and low trans spreadable fat rich in unsaturated and omega-3 fatty acids” and reduction of LDL-cholesterol concentrations pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2011;9(5):2168, 13 pp. https://doi.org/10.2903/j.efsa.2011.2168. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2011.2168/epdf
22. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2012a. Scientific Opinion on the substantiation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 2012;10(7):2809, 21 pp. https://doi.org/10.2903/j.efsa.2012.2809. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2012.2809/epdf
23. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2012b. Scientific Opinion on the substantiation of a health claim related to Vitis vinifera L. seeds extract and maintenance of normal venous blood flow pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 2012;10(12):2996, 11 pp. https://doi.org/10.2903/j.efsa.2012.2996. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2012.2996/pdf
24. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2013a. Scientific Opinion on the substantiation of a health claim related to Vichy Catalan carbonated natural mineral water and reduction of post-prandial lipaemic response pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 2013;11(2):3087, 12 pp. https://doi.org/10.2903/j.efsa.2013.3087. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2013.3087/epdf
25. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2013b. Scientific Opinion on the substantiation of a health claim related to the combination of artichoke leaf dry extract standardised in caffeoylquinic acids, monacolin K in red yeast rice, sugar-cane derived policosanols, OPC from French maritime pine bark, garlic dry extract standardised in allicin, d-α-tocopheryl hydrogen succinate, riboflavin and inositol hexanicotinate in Limicol® and reduction of blood LDL-cholesterol concentrations pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2013;11(7):3327, 16 pp. https://doi.org/10.2903/j.efsa.2013.3327. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2013.3327/epdf
26. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014a. Scientific Opinion on the substantiation of a health claim related to selenium and protection of DNA, proteins and lipids from oxidative damage pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2014;12(11):3890, 8 pp. https://doi.org/10.2903/j.efsa.2014.3890. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2014.3890/epdf
27. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014b. Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous tone pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 2014;12(1):3512, 10 pp. https://doi.org/10.2903/j.efsa.2014.3512. Available online : http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2014.3512/pdf
28. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014c. Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 2014;12(1):3511, 10 pp. https://doi.org/10.2903/j.efsa.2014.3511. http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2014.3511/pdf
29. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2015. Scientific Opinion on the substantiation of a health claim related to coffee C21, a coffee standardised by its content of caffeoylquinic acids, trigonelline and N-methylpyridinium, and reduction of DNA damage by decreasing spontaneous DNA strand breaks pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 2015;13(5):4099, 12 pp. Available online : http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2015.4099/epdf
30. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2016a. General scientific guidance for stakeholders on health claim applications. EFSA Journal 2016;14(1):4367, 38 pp. https://doi.org/10.2903/j.efsa.2016.4367. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2016.4367/epdf
31. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), Turck D, Bresson J-L, Burlingame B, Dean T, Fairweather-Tait S, Heinonen M, Hirsch-Ernst KI, Mangelsdorf I, McArdle HJ, Naska A, Neuhauser-Berthold M, Nowicka G, Pentieva K, Sanz Y, Sjödin A, Stern M, Tome D, Van Loveren H, Vinceti M, Willatts P, Martin A, Strain JJ, Ciok J and Siani A, 2016b. Scientific opinion on vitamin E and protection of DNA, proteins and lipids from oxidative damage: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2016;14(10):4588, 8 pp. https://doi.org/10.2903/j.efsa.2016.4588. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2016.4588/epdf
32. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), Turck D, Bresson J-L, Burlingame B, Dean T, Fairweather-Tait S, Heinonen M, Hirsch-Ernst KI, Mangelsdorf I, McArdle HJ, Naska A, Neuhauser-Berthold M, Nowicka G, Pentieva K, Sanz Y, Sjödin A, Stern M, Tome D, Van Loveren H, Vinceti M, Willatts P, Martin A, Strain JJ, Heng L, Valtueña Martínez and Siani A, 2017a. Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 2). EFSA Journal 2017;15(1):4680, 31 pp. https://doi.org/10.2903/j.efsa.2017.4680. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2017.4680/epdf
33. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), Turck D, Bresson J-L, Burlingame B, Dean T, Fairweather-Tait S, Heinonen M, Hirsch-Ernst KI, Mangelsdorf I, McArdle HJ, Naska A, Neuhauser-Berthold M, Nowicka G, Pentieva K, Sanz Y, Sjödin A, Stern M, Tome D, Van Loveren H, Vinceti M, Willatts P, Martin A, Strain JJ, Ciok J and Siani A, 2017b. Scientific opinion on Vitamin C and protection of DNA, proteins and lipids from oxidative damage: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2017;15(1):4685, 8 pp. https://doi.org/10.2903/j.efsa.2017.4685. Available online: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2017.4685/epdf
34. Jackson KG, Poppitt SD and Minihane AM, 2012. Postprandial lipemia and cardiovascular disease risk: Interrelationships between dietary, physiological and genetic determinants. Atherosclerosis, 220, 22–33.
35. Jagla A and Schrezenmeir J, 2001. Postprandial triglycerides and endothelial function. Experimental and Clinical Endocrinology & Diabetes, 109, S533–S537.
36. Kolovou GD, Mikhailidis DP, Kovar J, Lairon D, Nordestgaard BG, Ooi TC, Perez-Martinez P, Bilianou H, Anagnostopoulou K and Panotopoulos G, 2011. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Current Vascular Pharmacology, 9, 258–270.
37. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I and Struijker-Boudier H; European Network for Non-invasive Investigation of Large Arteries, 2006. Expert consensus document on arterial stiffness: methodological issues and clinical applications. European Heart Journal, 27, 2588–2605.
38. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, de van Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Rydén L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, de van Borne P, Vlachopoulos C, Volpe M and Wood DA, 2013. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal, 34, 2159–2219. Available online: https://www.ncbi.nlm.nih.gov/pubmed/23771844
39. Mihas C, Kolovou GD, Mikhailidis DP, Kovar J, Lairon D, Nordestgaard BG, Ooi TC, Perez-Martinez P, Bilianou H, Anagnostopoulou K and Panotopoulos Gl, 2011. Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis. Current Vascular Pharmacology, 9, 271–280.
40. Nordestgaard BG and Freiberg JJ, 2011. Clinical Relevance of Non-Fasting and Postprandial Hypertriglyceridemia and Remnant Cholesterol. Current Vascular Pharmacology, 9, 281–286. https://doi.org/10.2174/157016111795495585. Available online: http://www.eurekaselect.com/node/87928/article
41. Standing Committee on the Food Chain and Animal Health, 2007. Guidance on the implementation of Regulation (EC) No 1924/2006 on Nutrition and Health Claims made on Foods. Conclusions of the Standing Committee on the Food Chain and Animal Health. 14 December 2007. https://ec.europa.eu/food/sites/food/files/safety/docs/labelling_nutrition_claim_reg-2006-124_guidance_en.pdf
42. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME and Green DJ, 2011. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. American Journal of Physiology, Heart and Circulatory Physiology, 300, H2–H12. https://www.ncbi.nlm.nih.gov/pubmed/20952670
43. Tolonen H, Koponen P, Naska A, Männistö S, Broda G, Palosaari T and Kuulasmaa K, 2015. EHES Pilot Project. Challenges in standardization of blood pressure measurement at the population level. BMC Medical Research Methodology, 15, 33. Available online: https://bmcmedresmethodolbiomedcentral.com/articles/10.1186/s12874-015-0020-3
44. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, Filipovsky J, Huybrechts S, Mattace-Raso FU, Protogerou AD, Schillaci G, Segers P, Vermeersch S and Weber T, 2012. Artery Society; European Society of Hypertension Working Group on Vascular Structure and Function; European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. Journal of Hypertension, 30, 445–448. Available online: https://www.ncbi.nlm.nih.gov/pubmed/22278144